Global CAR-T development is bustling! Although Taiwan entered the CAR-T field late and faced hurdles like patents, several companies are targeting CAR-T and taking challenges to meet the unmet needs. Their clinical trials are expected to kick off in the US and/or Taiwan in 2024. Globalbio dives deeper, spotlighting the latest progress of six Taiwanese CAR-T therapy developers.
 
Stay tuned with #Globalbio for more updates. 
Read more: https://news.gbimonthly.com/tw/invest/show.php?num=63571
 
#CAR-T #MedicalInnovation #Healthcare #Biotech #celltherapy
#Ever Supreme Bio
#UWELL Biopharma
#PELL Bio-Med
#ARCE THERAPEUTICS
#TriArm Therapeutics
#GenomeFrontier Therapeutics